Read our breaking Ukraine coverage

Disruptive Technologies

Do U.S. biodefense efforts need systems analysis?

By Malcolm Dando | Biosecurity, Columnists

Stirring up “swine flu” hysteria

By Laura H. Kahn | Biosecurity, Columnists

Getting chemical weapons destruction back on track

By Jonathan B. Tucker, Paul F. Walker | Biosecurity, Opinion

Bioethicists enter the dual-use debate

By Malcolm Dando | Biosecurity, Columnists

Licensing life science researchers

By Laura H. Kahn | Biosecurity, Columnists

Unifying the U.S. government response to bioterrorism

By | Biosecurity, Special Topics

The body’s own bioweapons

By | Biosecurity, Special Topics

Biotechnology’s crossroads

By Malcolm Dando | Biosecurity, Columnists

Grassroot efforts to impede bioterrorism

By Stephen M. Maurer | Biosecurity, Opinion

The risks of the “pathogen research enterprise”

By Malcolm Dando | Biosecurity, Columnists

The threat of emerging ocean diseases

By Laura H. Kahn | Biosecurity, Columnists

Opportunities to improve the bioweapons regime

By Malcolm Dando | Biosecurity, Columnists